Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Spine BioPharma, Inc.

Spine BioPharma Announces Topline Results from Phase 3 MODEL Trial For SB-01 (vicatertide) In Chronic Low Back Pain Associated with Degenerative Disc Disease
From Spine BioPharma, Inc.
Via Business Wire
Spine BioPharma, Inc. to Present at the Canaccord Genuity 2025 Musculoskeletal Conference
From Spine BioPharma, Inc.
Via Business Wire
Spine BioPharma, Inc. to Present at Biotech Showcase 2025
From Spine BioPharma, Inc.
Via Business Wire
Spine BioPharma, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
From Spine BioPharma, Inc.
Via Business Wire
Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain
From Spine BioPharma, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.